Literature DB >> 33223086

Cannabinoids in Neurologic Illnesses.

Anup D Patel1.   

Abstract

Marijuana has been used to treat medical disease since well before the 1800s. Recently, increased use of cannabinoids, the chemical components of marijuana, have been seen to treat neurologic illness in children and adults. Unfortunately, data are lacking in treating most neurologic illnesses except in the field of epilepsy and pain from spasticity in multiple sclerosis. Therefore, formal conclusions about the potential efficacy, benefit, and adverse effects for most marijuana based products cannot be made at this time. Further research using gold standard scientific methodology should be performed to help address potential uses and safety for cannabinoids to treat neurologic illnesses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBD; Cannabidiol; Cannabinoids; Cannabis; Marijuana; Medical cannabis; Medical marijuana

Year:  2020        PMID: 33223086     DOI: 10.1016/j.ncl.2020.09.012

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  1 in total

1.  Characterization and Biological Activity of Fiber-Type Cannabis sativa L. Aerial Parts at Different Growth Stages.

Authors:  Giulia Mastellone; Arianna Marengo; Barbara Sgorbini; Federica Scaglia; Francesca Capetti; Francesco Gai; Pier Giorgio Peiretti; Patrizia Rubiolo; Cecilia Cagliero
Journal:  Plants (Basel)       Date:  2022-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.